Kenneth d’Entremont
Patrimonio netto: 5 M $ in data 30/06/2026
Patrimonio netto: 5 M $ in data 30/06/2026
Mr. Kenneth d’Entremont is a Chief Executive Officer & Director at Medexus Pharmaceuticals, Inc. He is on the Board of Directors at Medexus Pharmaceuticals, Inc. Mr. d’Entremont was previously employed as a President, Chief Executive Officer & Director by Medexus, Inc. and a General Manager & VP-Business Development by Sanofi Canada, Inc. He received his undergraduate degree from McMaster University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 01/12/2025 | 1.504.807 ( 4,75% ) | 5 M $ | 30/06/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| MEDEXUS PHARMACEUTICALS INC. | Amministratore Delegato | 17/12/2018 |
| Società | Posizione | Fine |
|---|---|---|
Medexus, Inc.
Medexus, Inc. Drugstore ChainsRetail Trade Engages in licensing, registration, marketing, sales and distribution of pharmaceutical products | Fondatore | 17/12/2018 |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Corporate Officer/Principal | 01/01/1999 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 4 |
|---|---|
McMaster University
McMaster University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medexus Pharmaceuticals, Inc.
Medexus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Provides healthcare products which focuses on therapeutic areas of auto-immune disease and pediatrics | Health Technology |
Sanofi Canada, Inc.
Sanofi Canada, Inc. Pharmaceuticals: MajorHealth Technology Researches, develops, manufactures and distributes pharmaceutical products | Health Technology |
Medexus, Inc.
Medexus, Inc. Drugstore ChainsRetail Trade Engages in licensing, registration, marketing, sales and distribution of pharmaceutical products | Retail Trade |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale